Treace Medical Concepts/TMCI

$14.38

0.34%
-
1D1W1MYTD1YMAX

About Treace Medical Concepts

Treace Medical Concepts, Inc. is a medical technology company. The Company’s Lapiplasty three-dimensional (3D) Bunion Correction System is a combination of instruments, implants and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. The Lapiplasty System combines its novel surgical approach, the Lapiplasty Procedure, with its procedural instrumentation and single-use implant kits. The Company is also providing Adductoplasty Midfoot Correction System, designed for reproducible correction of the midfoot to provide further support to hallux valgus patients. The Lapiplasty and Adductoplasty Systems are comprised of single-use implant kits and reusable instrument trays. The Company also commercialized new products that address ancillary surgical procedures performed routinely in connection with the Lapiplasty Procedure.

Ticker

TMCI

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

John Treace

Employees

423

Headquarters

Ponte vedra, United States

TMCI Metrics

BasicAdvanced
$883.82M
Market cap
-
P/E ratio
-$0.79
EPS
-
Beta
-
Dividend rate

What the Analysts think about TMCI

Analyst Ratings

Majority rating from 7 analysts.
Buy

Price Targets

Average projection from 7 analysts.
5.29% upside
High $18.00
Low $11.00
$14.38
Current price
$15.14
Average price target

TMCI Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-42.99% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$40.7M
-2.86%
Net income
$-17.5M
43.44%
Profit margin
-42.99%
47.68%

TMCI Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 12.9%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.23
-$0.20
-$0.28
-$0.10
-
Expected
-$0.23
-$0.24
-$0.26
-$0.09
-$0.18
Surprise
0.73%
-16.08%
7.1%
12.9%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Treace Medical Concepts stock

Buy or sell Treace Medical Concepts stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing